Periodontitis,
does it really help with Increased incidence of rheumatoid arthritis?
research showsThe grade is D. In a Danish cohort of 3,308,903 people followed for up to 18 years, the HR for rheumatoid arthritis after periodontitis was 1.05 (95% CI 0.88 to 1.25), with only a one-day difference in restricted mean survival time over 18 years. Exposure came from administrative care codes, and direct smoking data were unavailable. The score is 30.
ads claimCo-occurrence and proposed biology do not establish that gum disease causes rheumatoid arthritis. Incident disease and short-term change in activity of existing rheumatoid arthritis after dental treatment are different questions.
Useful facts when choosing a product
- Exposure was defined through periodontal diagnosis and treatment codes rather than clinical probing severity.
- The 18-year restricted mean survival-time difference for incident rheumatoid arthritis was one day.
- After simulated smoking confounding, the cross-sectional prevalence ratio was 0.99 (95% simulation interval 0.93 to 1.04).
What the research actually shows
The cohort included 3,308,903 Danish residents aged 20 to 79 who were free of both recorded conditions during the preceding ten years and were followed from 2000 through 2017. There were 740,799 periodontitis and 20,348 rheumatoid arthritis events. Exposure was based on diagnosis and treatment codes, not a full clinical periodontal examination. Reverse causation was addressed by a ten-year disease-free lookback, bidirectional time-varying analyses, and marginal structural survival models. Smoking was not directly available in the longitudinal model; simulating smoking confounding moved the separate cross-sectional prevalence ratio from 1.15 to 0.99 (95% simulation interval 0.93 to 1.04).
Why this is classified as D (30)
A very large cohort found HR 1.05 (0.88 to 1.25), but administrative code exposure and the absence of direct smoking data create substantial misclassification and residual-confounding concerns, giving D with 30 points.
Counterpoint. Whether periodontal treatment changes short-term activity of established rheumatoid arthritis is a separate efficacy question.
Rejudgment record. Cross-check applied — Null nationwide cohort estimate with absent direct smoking data and administrative care-code exposure limitations
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Increased rheumatoid arthritis incidence after periodontitis | D | The adjusted HR and absolute difference were essentially null. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Observational cohort using time-varying marginal structural survival models | 20,348 | Nonprofit support from Aarhus University Research Foundation and the Danish Rheumatism Association | Incident rheumatoid arthritis diagnosis | HR 1.05 (95% CI 0.88 to 1.25) after periodontitis; one-day restricted mean survival-time difference over 18 years | Decisive long-term observational evidence |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-04).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none
Cite this verdict
[Chamgap] Periodontitis x incident rheumatoid arthritis — Evidence Grade D·30. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/periodontitis-incident-rheumatoid-arthritis/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.